3.70 EUR

Opening hours: 09:00 - 17:30 (Central European Standard Time: 11/28/2024 3:46:52 AM)
Exchange closed, opens in 5 hours 13 minutes
0.00 EUR (0.00%)
-1.60 EUR (-1.60%)
-0.54 EUR (-0.54%)
-11.69 EUR (-11.69%)
-10.41 EUR (-10.41%)
221.74 EUR (221.74%)
77.88 EUR (77.88%)
48.59 EUR (48.59%)

About genOway SA

Market Capitalization 30.05M

genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoint mouse models; immunodeficient and reconstituted mouse and rat strains models; humanized immune target models; other mouse and rat catalog models; and cell lines. It serves pharmaceutical and life science companies, and academic institutes. The company was incorporated in 1999 and is based in Lyon, France.

Headquarters (address)

Technopark 2

Lyon 69007

France

Phone33 4 37 65 41 00
Websitehttps://www.genoway.com
Employees0
SectorHealthcare
IndustryBiotechnology
TickerALGEN
ExchangeEuropean Stock Exchange
CurrencyEUR
52 week range3.24 - 4.91
Market Capitalization30.05M
P/E trailing17.62
P/E forward24.67
Price/Sale1.07
Price/Book2.02
Beta0.550
EPS0.210
EPS France (ID:70, base:331) 3.06

CleverShares.com|
2024 ©

1.0.9097.27347